Cell and Gene Therapy Market accounted for US$ 2.38 billion in 2020 and is projected to register a moderate CAGR of 35.50% prophecymarketinsights.com

The major factor driving the global cell and gene therapy market is an increased pool of patients with various diseases, product launches and approvals. Also, favorable regulatory support and special designations for cell and gene therapy products, growing demand for car t-cell therapy products. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include drug approvals and a strong pipeline of cell and gene therapies.